Effect of early enteral nutrition on postoperative nutritional status, and immune function in elderly patients with esophageal cancer or cardiac cancer

Chinese Journal of Cancer Research

Volumn 25, Issue 3, 2013, Pages 299-305

  Yu, Guiping ^a   Chen, Guoqiang ^a   Huang, Bin ^a   Shao, Wenlong ^b,c   Zeng, Guangqiao ^c  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxin; Enteral nutrition; Immune function; Intestinal permeability; Nutritional status

Indexed keywords

ALBUMIN; AMINE OXIDASE (COPPER CONTAINING); CD4 ANTIGEN; ENDOTOXIN; GLUCOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFUSION FLUID; INTERLEUKIN 2; INTERLEUKIN 6; LACTIC ACID; NUTRISON FIBRE; PEPTISORB; POTASSIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; DEFECATION; DRUG DOSE INCREASE; EARLY INTERVENTION; ENTERIC FEEDING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; FLATULENCE; GERIATRIC CARE; GERIATRIC DISORDER; HEART CANCER; HOSPITALIZATION; HUMAN; IMMUNE STATUS; INTESTINE MUCOSA PERMEABILITY; LACTATE BLOOD LEVEL; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PARENTERAL NUTRITION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; STRESS ULCER; SURGICAL MORTALITY; THERAPY EFFECT; TURBIDIMETRY;

EID: 84883325980     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2013.06.01     Document Type: Article

References (24)

1. Chen W, He Y, Zheng R, et al. Esophageal cancer incidence and mortality in China, 2009. J Thorac Dis 2013;5:19-26.
2. Niu J, Weber J, Gelbspan D. Change of HER2 status in metastatic esophageal adenocarcinoma: heterogeneity of the disease? Case report and review of literature. J Gastrointest Oncol 2012;3:358-61.
3. Khan O, Nizar S, Vasilikostas G, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. J Thorac Dis 2012;4:465-6.
4. Fernández-Sordo JO, Konda VJ, Chennat J, et al. Is Endoscopic Ultrasound (EUS) necessary in the pretherapeutic assessment of Barrett's esophagus with early neoplasia? J Gastrointest Oncol 2012;3:314-21.
5. Cuesta MA, Biere SS, Henegouwen MI, et al. Randomised trial, Minimally Invasive Oesophagectomy versus open oesophagectomy for patients with resectable oesophageal cancer. J Thorac Dis 2012;4:462-4.
6. Ling Y, Chen J, Tao M, et al. A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma. J Thorac Dis 2012;4:58-62.
7. Jensen K, Afroze S, Munshi MK, et al. Mechanisms for nicotine in the development and progression of gastrointestinal cancers. Transl Gastrointest Cancer 2012;1:81-7.
8. Chen WQ, Zheng RS, Zhang SW, et al. Report of incidence and mortality in china cancer registries, 2008. Chin J Cancer Res 2012;24:171-80.
9. Kennedy L, Hodges K, Meng F, et al. Histamine and histamine receptor regulation of gastrointestinal cancers. Transl Gastrointest Cancer 2012;1:215-27.
10. Uzunoglu FG, Reeh M, Kutup A, et al. Surgery of esophageal cancer. Langenbecks Arch Surg 2013;398:189-93.
11. Groblewska M, Mroczko B, Sosnowska D, et al. Interleukin 6 and C-reactive protein in esophageal cancer. Clin Chim Acta 2012;413:1583-90.
12. Anderson MR, Jankowski JA. The treatment, management and prevention of oesophageal cancer. Expert Opin Biol Ther 2001;1:1017-28.
13. Farthing MJ, Fitzgerald R, Zhang ZW. Acid, helicobacter and immunity: a new paradigm for oesophagogastric cancer. J Physiol Paris 2001;95:423-7. (Pubitemid 33020270)
14. Makino H, Kunisaki C, Kosaka T, et al. Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer. Br J Surg 2011;98:975-82.
15. Shah MB, Schnoll-Sussman F. Novel use of cryotherapy to control bleeding in advanced esophageal cancer. Endoscopy 2010;42 Suppl 2:E46.
16. Experts Committee on Cancer -Related Anemia, Chinese Society of Clinical Oncology (CSCO). Clinical practice guidelines on cancer-related anemia (2012-2013 Edition). Chin Clin Oncol 2012;1:18.
17. Wagner IJ, Rombeau JL. Nutritional support of surgical patients with inflammatory bowel disease. Surg Clin North Am 2011;91:787-803, viii.
18. Zhan P, Wang Q, Qian Q, et al. Megestrol acetate in cancer patients with anorexia-cachexia syndrome: a metaanalysis. Transl Cancer Res 2013;2:74-9.
19. Zou XP, Chen M, Wei W, et al. Effects of enteral immunonutrition on the maintenance of gut barrier function and immune function in pigs with severe acute pancreatitis. JPEN J Parenter Enteral Nutr 2010;34:554-66.
20. Havenaar R. Intestinal health functions of colonic microbial metabolites: a review. Benef Microbes 2011;2:103-14.
21. Bastian L, Weimann A. Immunonutrition in patients after multiple trauma. Br J Nutr 2002;87 Suppl 1:S133-4. (Pubitemid 34134113)
22. Van Hauwermeiren F, Vandenbroucke RE, Libert C. Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1. Cytokine Growth Factor Rev 2011;22:311-9.
23. Barlow JL, McKenzie AN. Nuocytes: expanding the innate cell repertoire in type-2 immunity. J Leukoc Biol 2011;90:867-74.
24. Yoshimura A, Wakabayashi Y, Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 2010;147:781-92.